ArticleMolecular genetics and metabolism2026
Comprehensive analysis of hearing function in Morquio A syndrome: Implications for diagnosis and management.
Article in Molecular genetics and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Morquio A syndrome (mucopolysaccharidosis IVA) is a lysosomal storage disorder characterized by systemic skeletal dysplasia and multisystem involvement. Hearing loss is frequently reported but remains insufficiently characterized, with few studies incorporating comprehensive behavioral and electrophysiologic assessments. In this prospective study, the largest Morquio A auditory cohort to date, participants underwent detailed audiologic and imaging testing at Nemours Children's Health as part of the National Institutes of Health-sponsored natural history program. Assessments included pure-tone thresholds, speech-recognition thresholds, speech perception in quiet and noise, tympanometry, distortion-product otoacoustic emissions, auditory brainstem responses, and cortical auditory evoked potentials. Outcomes included the prevalence, type, and severity of hearing loss, as well as associations with age and clinical disease severity. Hearing loss was identified in 50.9% of 56 patients, with sensorineural loss more frequent than conductive or mixed types. Prevalence of hearing loss was significantly correlated with clinical severity (height percentile), whereas no significant correlation was observed between hearing loss severity and diagnostic age. Reduced or absent otoacoustic emissions with preserved brainstem and cortical responses indicate predominant cochlear involvement with potential secondary central contributions. Comprehensive imaging of the middle and inner ear showed no significant structural differences between patients with and without hearing loss. Hearing loss is common in Morquio A and is primarily sensorineural. The absence of associations with age or disease severity underscores the heterogeneity of auditory involvement. These findings emphasize the need for routine, comprehensive audiologic monitoring to support early detection and mitigate long-term impacts on communication and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.